A meta-analysis of clinically ascertained lipoedema cohorts from the UK and Spain identifies overlapping susceptibility loci with the UK Biobank

Résumé fourni par la source

Abstract Lipoedema is a chronic adipose tissue disorder mainly affecting women with excess subcutaneous fat deposition on the lower limbs, associated with pain and tenderness. There is often a family history of lipoedema, suggesting a genetic origin, but the contribution of genetics is not well studied. We conducted a genome-wide association study (GWAS) for this disorder in a clinically ascertained cohort from Spain and performed a meta-analysis with the UK lipoedema cohort GWAS. We then used the results of this study as a replication of the inferred UK Biobank “lipoedema phenotype” study. Whilst our meta-analysis alone did not identify any genome-wide significant associations, our clinical cohorts provide support for three loci identified through the UKBB study: the chr2q24.3 GRB14-COBLL1 locus (rs6753142, P META =1.64x10 -6 ), chr6p21.1 VEGFA locus (rs4711750, P META =8.99x10 -7 ) and the chr5q11.2 ANKRD55-MAP3K1 locus (rs3936510, P META =1.67x10 -5 ). We identify numerous rare SNPs with strong association signals in our meta-analysis ( P <1x10 -6 ) with support in both UK and Spanish datasets, three of which also show nominal support in the UKBB ( P <0.05). These findings provide a starting point towards understanding the genetic basis of clinical lipoedema and demonstrate the utility of the interplay of large-scale biobanks genetic data and clinically ascertained cohorts to elucidate the genetic architecture of lipoedema.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.